<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - FDA Authorizes Moderna's COVID-19 Vaccine
Image Overlay - FDA Authorizes Moderna's COVID-19 Vaccine

FDA Authorizes Moderna's COVID-19 Vaccine

FDA Authorizes Moderna's COVID-19 Vaccine

After approving Pfizer's COVID-19 vaccine three weeks ago, the FDA has now authorized Moderna's vaccine against the Coronavirus for individuals 18 years or older. The FDA based its recommendation on data analysis from the pivotal Phase III clinical study, which showed a primary vaccine efficacy rate of 94.1%. Under Operation Warp Speed, approximately 20 million doses will be delivered tp the U.S. government by the end of December 2020. As an organization, Yourway looks forward to supporting the massive vaccine distribution effort.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?